Daniel Virnich Receives Stock Award at Oncology Institute Inc (TOI) — SEC Form 4, Nov 14, 2025

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
TXN 2025-11-12 · FILED 2025-11-14
Equity Position 1.79M sh 1,787,309 → 1,793,520
Equity Change +0.4% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2025-11-14
Report Date
2025-11-12
Accession No.
0001079973-25-001765
Accepted At
2025-11-14 21:30 UTC
Reporting Owner
Name Relationship
Daniel Virnich CIK 0001891107
CEO
Daniel Virnich at Oncology Institute Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Oncology Institute Inc
2026-05-22 Gift/Other — View
2026-04-02 Award — View
2026-03-18 Gift/Other — View
2025-11-19 Award — View
2025-05-22 - — View
All filings by this insider at Oncology Institute Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2025-11-12 A - Award/Grant 6,211 A $0.00 — 1,793,520 Direct
Footnotes (1)
F1
Represents RSU awards that were fully vested upon grant, net of withholding tax obligations. Show more
5%+ Holders · 13D/G 3 filers
Other insiders at Oncology Institute Inc
All Oncology Institute Inc insider activity
GET /v1/forms/4/0001079973-25-001765 API docs
View Original SEC Filing